Jan 21, 2019 04:05 PM EST
A protein-secreting device implanted into the hippocampus of epileptic rats reduces seizures by 93 percent in three months, finds preclinical research published in JNeurosci. These results support ongoing development of this technology and its potential translation into a new treatment for epilepsy.
Motivated by an unmet need for effective and well-tolerated epilepsy therapies, Giovanna Paolone and colleagues of the University of Ferrara, Italy and of Gloriana Therapeutics, Inc. (Providence, RI) investigated the effects of the Gloriana targeted cellular delivery system for glial cell line-derived neurotrophic factor (GDNF) -- a protein recent research suggests may help suppress epileptic activity.
In addition to quickly and progressively reducing seizures in male rats -- by 75 percent within two weeks -- the researchers found their device improved rats' anxiety-like symptoms and their performance on an object recognition task, indicating improvement in cognition.
The treatment also corrected abnormalities in brain anatomy associated with epilepsy. These effects persisted even after the device was removed, indicating this approach may modify the disease progression.
2. 10:01 AM
Citizen scientist finds ancient white dwarf star encircled by puzzling rings
3. 09:07 AM
Porous carbon fiber research one step closer to use in automotive industry
4. 08:46 AM
Technologies for removing CO2 will need to be integrated into climate policy in 2019
2. 10:02 AM
New source of fuel: converting methanol to ethanol using ultraviolet light
3. Feb 14, 2019
Waste brine from desalination: A useful source of chemicals
4. 08:25 AM
Jobs vs. death toll: Calculating corporate death penalties